Prolacta Bioscience

About:

Prolacta Bioscience provides human milk-based nutritional products for premature infants in the neonatal intensive care unit (NICU).

Website: http://www.prolacta.com

Twitter/X: prolacta

Top Investors: Draper Associates, Revelation Partners, Alta Partners, PROOF, Aisling Capital

Description:

Prolacta Bioscience, Inc. (www.prolacta.com) is a life science company founded by serial entrepreneur, Elena Medo who has dedicated her career to improving quality of life for sick infants by Advancing the Science of Human MilkTM. Prolacta creates specialty formulations made exclusively from human milk for the nutritional needs of critically ill, premature infants in neonatal intensive care units. It is the first and only company to provide a human milk fortifier made from 100% human milk, Prolact+ H2MF. They operate a pharmaceutical grade processing plant and have designed and patented processes that enable them to make their one-of-a-kind life saving products. Prolacta is committed to making a meaningful difference in the lives of the most vulnerable infants through world-class research and innovative products.